Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

U-Tryp 100000 IU Injection (4 ml)

U-Tryp 100000 IU Injection is a protease inhibitor containing Ulinastatin (100000 IU). It is used to treat acute pancreatitis, systemic inflammatory response syndrome (SIRS), and other conditions involving inflammation and enzyme-related tissue damage. It helps reduce inflammation and organ damage by inhibiting enzyme activity and modulating the immune response.

In stock
SKU
SBUT09634
Price: 0.00 (Inclusive of Taxable Goods)
U-Tryp 100000 IU Injection (4 ml) is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Contains Ulinastatin, a broad-spectrum protease inhibitor

  • Minimizes inflammation in conditions like acute pancreatitis and sepsis

  • Parenteral formulation ensures rapid onset of action

  • Manufactured by Bharat Serums and Vaccines Ltd

  • Used in critical care and hospital settings

  • Suitable for adult and pediatric patients (as advised by physician)

Technical Details
Technical Specification
  • Generic Name: Ulinastatin

  • Brand Name: U-Tryp

  • Strength: 100000 IU

  • Form: Injection

  • Volume: 4 ml

  • Route of Administration: Parenteral (Intravenous/Intramuscular)

  • Packaging: Single vial (4 ml)

  • Category: Prescription medication

  • Manufacturer: Bharat Serums and Vaccines Ltd

  • Consume Type: Parenteral

  • 4 ml Injection
  • Effective inflammation control in acute and life-threatening conditions

  • Prevents tissue damage caused by excessive enzyme activity

  • Reduces complications in acute pancreatitis, post-operative inflammation, and sepsis

  • Safe for use under strict medical supervision

  • Rapid bioavailability through IV administration

  • Supports recovery of organ function during critical illness

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.